Biosceptre Revenue and Competitors
Estimated Revenue & Valuation
- Biosceptre's estimated annual revenue is currently $4.5M per year.
- Biosceptre's estimated revenue per employee is $155,000
Employee Data
- Biosceptre has 29 Employees.
- Biosceptre grew their employee count by 7% last year.
Biosceptre's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Business Officer | Reveal Email/Phone |
2 | Clinical Operations Director | Reveal Email/Phone |
3 | Senior Research Manager | Reveal Email/Phone |
4 | Biologics Production Manager | Reveal Email/Phone |
Biosceptre Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Biosceptre?
Biosceptre is a biopharmaceutical company developing targeted therapeutics and immune-oncology products against nfP2X7, a cancer target that has been shown to be present on the majority of cancers. Our goal is to bring novel therapeutics to patients suffering from a wide range of malignancies.
keywords:N/AN/A
Total Funding
29
Number of Employees
$4.5M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2M | 29 | 38% | $35M |
#2 | $2.9M | 29 | N/A | N/A |
#3 | $300M | 29 | -9% | $63.7M |
#4 | $3.5M | 29 | 7% | N/A |
#5 | $3M | 29 | -3% | N/A |